CINCINNATI, Feb. 6 /PRNewswire/ — Great Plains – The Camelina Company announces that camelina meal will be available for use as broiler chicken feed. The Food and Drug Administration (FDA) today approved camelina in rations for broiler chickens and with this action the FDA allows Great Plains to state that camelina has GRAS (“generally recognized as safe”) status.
Camelina already is used in feed mixtures for beef cattle and hogs.
While high Read the rest of this entry »

This communication contains “forward-looking statements” which represent the current expectations and beliefs of management of Barr Pharmaceuticals, Inc. (the “Company”) concerning the proposed merger of the Company with Boron Acquisition Corp., a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd. (the “merger”) and other future events and their potential effects on the Company. The statements, analyses, and other information contained Read the rest of this entry »

next to the proton therapy radiation center the hospital is building with the private company ProCure.
The 48,000-square-foot cancer treatment center will cost $35.5 million. It will offer patients all cancer treatment services including radiation therapy and chemotherapy and supporting services such as diagnostic imaging, nutritional counseling and social work.
The Winfield-based hospital recently entered into a 10-year clinical affiliation with Read the rest of this entry »

The Boston Redevelopment Authority approved plans for a new LA/Fitness Club in a West Roxbury shopping center located on the V.F.W. Parkway.
The project includes the renovation of an existing vacant retail space formerly occupied by Stop & Shop into an approximately 48,900 square-foot new fitness facility.
Creation of pedestrian path from both V.F.W. Parkway and Gardner Street into the main building
Improvement of the lightings on the project Read the rest of this entry »

EAST HANOVER, N.J., Nov. 12 /PRNewswire/ — The US Food and Drug
Administration (FDA) has approved a 30-minute onset of action for Focalin(R)
XR (dexmethylphenidate HCl) extended-release capsules for the treatment of
Attention Deficit/Hyperactivity Disorder (ADHD), bringing potential benefits
for young patients and their families during the important morning period when
they are preparing for school.
“The morning is a critical time for families,” Read the rest of this entry »

Earlier this month, the U.S. Food and Drug Administration approved the first drug produced from animals that have been injected with a human gene, paving the way for a new class of biotechnology drugs which could potentially be mass-produced at much lower cost than current therapies.
The drug utilizes an anti-clotting protein called antithrombin, which can prevent fatal blood clots caused by a rare disorder in people who are deficient in the protein.
Read the rest of this entry »

. Food and Drug Administration issued its first approval for a biological product produced by genetically engineered (
) animals.
The approval is for ATryn, an anticoagulant used for the prevention of blood clots in patients with a rare disease known as hereditary antithrombin (AT) deficiency. These patients are at high risk of blood clots during medical interventions, such as surgery, and before, during and after childbirth.
ATryn is a therapeutic Read the rest of this entry »

Other researchers had previously begun human testing of embryonic cells derived from adults and fetuses, but the new study will mark the first authorized use of those derived from embryos, which have been highly controversial because the embryos are destroyed in the process.
The Food and Drug Administration approved a request from Geron of Menlo Park to test the stem cells on eight to 10 patients with severe spinal cord injuries. The study, which Read the rest of this entry »

Tuesday, January 20, 2009
, Inc., from Milford, Connecticut, to market the firm’s XPERT 20™ tabletop digital radiography system, which was designed for visualization of biopsy specimens, such as breast tissue samples from stereotactic core biopsies. The firm believes that its system will be ideal for smaller clinical facilities, since it is reasonably priced and the device is meant to fit into confined spaces of cramped pathology labs.
This Read the rest of this entry »

Using stem cells is controversial because embryonic stem cells are taken from human fetuses. 
Earlier this month, Glasgow researchers were planning a “major trial” to test the
, according to the BBC. The United Kingdom approved the trial after the US Food and Drug Administration rejected the proposal from ReNeuron, the company that developed the therapy, two years ago.
According to Medical News Today, “
. However, the rest Read the rest of this entry »